• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ILD-GAP 指数在纤维化性过敏性肺炎队列中预测死亡率的研究。

Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort.

机构信息

Pulmonology Department, Centro Hospitalar e Universitário de São João, Alameda Prof. Hernâni Monteiro, Porto 4200-319, Portugal.

Pulmonology Department, Hospital Pedro Hispano, Matosinhos, Portugal.

出版信息

Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221135316. doi: 10.1177/17534666221135316.

DOI:10.1177/17534666221135316
PMID:36476249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9742694/
Abstract

BACKGROUND

Fibrotic hypersensitivity pneumonitis (fHP) is associated with significant morbidity and mortality. Interstitial lung disease-gender-age-physiology (ILD-GAP) performance in fHP outside the initial cohort was never performed.

AIM

To assess the ILD-GAP index's ability to predict mortality in a Portuguese cohort of patients with fHP and analyse whether other clinical variables add value.

METHODS

Retrospective analysis of fHP cohort in two Portuguese ILD centres. The baseline ILD-GAP index was calculated. Survival was analysed in months; mortality was the primary outcome. Univariate and multivariate analyses to identify mortality risk factors were performed.

RESULTS

A total of 141 patients were included. Fifty-three patients (37.6%) died during the follow-up. The usual interstitial pneumonia (UIP) pattern was found in 49.6%, and their survival was inferior to non-UIP [32 months (interquartile range, IQR = 19, 60) versus 52 months (IQR = 28, 98),  = 0.048]. Patients with an ILD-GAP index higher than three double their risk of mortality [hazard ratio (HR) = 6.48, 95% confidence interval (CI) = (3.03-13.96)] when compared with the patients with an index between 2 and 3 [HR = 3.04, 95% CI = (1.62-5.71)] adjusting for acute exacerbation history. Even though UIP patients had worse survival, it did not reach statistical significance when UIP pattern was added to this model. Acute exacerbation history was an independent risk factor for mortality; however, ILD-GAP still predicted mortality after adjusting for this factor. PaO and 6-minute walk test desaturation were not significant risk factors.

CONCLUSION

ILD-GAP index is a good predictor for mortality in fHP, even after adjusting for other mortality risk factors.

摘要

背景

纤维化性过敏性肺炎(fHP)与较高的发病率和死亡率相关。ILD-GAP 评分在最初队列之外的 fHP 中的表现从未被评估过。

目的

评估 ILD-GAP 指数在葡萄牙 fHP 患者队列中的预测死亡率的能力,并分析其他临床变量是否具有附加价值。

方法

对葡萄牙两家间质性肺病中心的 fHP 队列进行回顾性分析。计算基线 ILD-GAP 指数。以月为单位分析生存情况;死亡率为主要终点。进行单变量和多变量分析以确定死亡风险因素。

结果

共纳入 141 例患者,53 例(37.6%)在随访期间死亡。49.6%的患者存在寻常型间质性肺炎(UIP)模式,其生存率低于非 UIP 模式[32 个月(四分位距,IQR=19,60)与 52 个月(IQR=28,98),=0.048]。ILD-GAP 指数大于 3 的患者死亡风险是指数在 2 到 3 之间的患者的两倍[风险比(HR)=6.48,95%置信区间(CI)=(3.03-13.96)],调整急性加重史后[HR=3.04,95%CI=(1.62-5.71)]。尽管 UIP 患者的生存率较差,但在将 UIP 模式添加到该模型后,其差异并未达到统计学意义。急性加重史是死亡的独立危险因素;然而,在调整了该因素后,ILD-GAP 仍然预测了死亡率。PaO 和 6 分钟步行试验的低氧饱和度不是显著的危险因素。

结论

即使在调整了其他死亡风险因素后,ILD-GAP 指数也是 fHP 死亡率的良好预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/4a047fa15c7a/10.1177_17534666221135316-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/30b843c3f6db/10.1177_17534666221135316-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/130cdde630d6/10.1177_17534666221135316-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/4a047fa15c7a/10.1177_17534666221135316-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/30b843c3f6db/10.1177_17534666221135316-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/130cdde630d6/10.1177_17534666221135316-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6b6/9742694/4a047fa15c7a/10.1177_17534666221135316-fig3.jpg

相似文献

1
Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort.ILD-GAP 指数在纤维化性过敏性肺炎队列中预测死亡率的研究。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221135316. doi: 10.1177/17534666221135316.
2
Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.特发性肺纤维化和纤维化性过敏性肺炎临床实践指南中放射学模式的整合与应用
Chest. 2023 Dec;164(6):1466-1475. doi: 10.1016/j.chest.2023.07.068. Epub 2023 Aug 2.
3
Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study.多学科讨论(MDD)诊断的纤维化间质性肺疾病(F-ILD)中影响长期结局的因素:一项前瞻性队列研究。
Eur J Med Res. 2024 Jan 30;29(1):91. doi: 10.1186/s40001-024-01673-2.
4
Predicting survival across chronic interstitial lung disease: the ILD-GAP model.预测慢性间质性肺病的生存情况:ILD-GAP 模型。
Chest. 2014 Apr;145(4):723-728. doi: 10.1378/chest.13-1474.
5
Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis: imaging trajectories and predictors of fibrotic progression and acute exacerbation.慢性过敏性肺炎患者的 CT 表现的动态变化:纤维化进展和急性加重的影像学轨迹和预测因素。
Eur Radiol. 2021 Jun;31(6):3993-4003. doi: 10.1007/s00330-020-07469-2. Epub 2020 Nov 25.
6
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.ILD-GAP 联合单核细胞比率可能比 ILD-GAP 更能预测间质性肺疾病患者的预后。
BMC Pulm Med. 2024 Jan 5;24(1):16. doi: 10.1186/s12890-023-02833-6.
7
Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis.基于计算机的自动CT分层作为过敏性肺炎预后的预测指标
Eur Radiol. 2017 Sep;27(9):3635-3646. doi: 10.1007/s00330-016-4697-4. Epub 2017 Jan 27.
8
Acute exacerbations of fibrotic interstitial lung diseases.纤维化间质性肺疾病的急性加重。
Respirology. 2020 May;25(5):525-534. doi: 10.1111/resp.13682. Epub 2019 Aug 19.
9
Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.非纤维化区域马赛克衰减作为非寻常型间质性肺炎病理诊断的预测因子。
Sci Rep. 2022 May 4;12(1):7289. doi: 10.1038/s41598-022-10750-7.
10
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.

引用本文的文献

1
Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD.流式细胞术对间质性肺疾病患者支气管肺泡灌洗淋巴细胞和中性粒细胞定量分析的预测价值
Cells. 2024 Dec 13;13(24):2066. doi: 10.3390/cells13242066.
2
Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer.间质肺病性别-年龄-生理学指数对肺癌手术治疗的影响。
Int J Clin Oncol. 2024 Oct;29(10):1475-1482. doi: 10.1007/s10147-024-02600-5. Epub 2024 Aug 24.
3
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study.

本文引用的文献

1
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
2
Insights on chronic hypersensitivity pneumonitis' treatment: Factors associated with a favourable response to azathioprine.慢性过敏性肺炎治疗的见解:与硫唑嘌呤良好反应相关的因素
Life Sci. 2021 May 1;272:119274. doi: 10.1016/j.lfs.2021.119274. Epub 2021 Feb 20.
3
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.
进行性纤维化性过敏性肺炎的预后因素:一项大型回顾性多中心观察性队列研究
ERJ Open Res. 2024 Feb 26;10(1). doi: 10.1183/23120541.00405-2023. eCollection 2024 Jan.
4
Hypersensitivity Pneumonitis: Challenges of a Complex Disease.过敏性肺炎:一种复杂疾病的挑战。
Can Respir J. 2024 Jan 18;2024:4919951. doi: 10.1155/2024/4919951. eCollection 2024.
5
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.ILD-GAP 联合单核细胞比率可能比 ILD-GAP 更能预测间质性肺疾病患者的预后。
BMC Pulm Med. 2024 Jan 5;24(1):16. doi: 10.1186/s12890-023-02833-6.
6
Impact of HRCT pattern on six-minute walk test in patients with interstitial lung disease-An observational study.高分辨率CT模式对间质性肺疾病患者六分钟步行试验的影响——一项观察性研究。
Lung India. 2023 Sep-Oct;40(5):429-433. doi: 10.4103/lungindia.lungindia_165_23.
7
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly.欧洲呼吸学会2021年国际大会:间质性肺疾病研讨会亮点
ERJ Open Res. 2022 May 23;8(2). doi: 10.1183/23120541.00640-2021. eCollection 2022 Apr.
成人过敏性肺炎的诊断。美国胸科学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
4
Impact of Azathioprine use in chronic hypersensitivity pneumonitis patients.在慢性过敏性肺炎患者中使用硫唑嘌呤的影响。
Pulm Pharmacol Ther. 2020 Feb;60:101878. doi: 10.1016/j.pupt.2019.101878. Epub 2019 Dec 17.
5
Hypersensitivity pneumonitis: Main features characterization in a Portuguese cohort.过敏性肺炎:葡萄牙队列中的主要特征描述。
Pulmonology. 2020 May-Jun;26(3):130-137. doi: 10.1016/j.pulmoe.2019.09.004. Epub 2019 Oct 29.
6
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
7
Acute exacerbations of fibrotic interstitial lung diseases.纤维化间质性肺疾病的急性加重。
Respirology. 2020 May;25(5):525-534. doi: 10.1111/resp.13682. Epub 2019 Aug 19.
8
The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease.ILD-GAP 风险预测模型在肌炎相关性间质性肺疾病中的表现不佳。
Respir Med. 2019 Apr;150:63-65. doi: 10.1016/j.rmed.2019.02.015. Epub 2019 Feb 21.
9
Long-term outcomes in chronic hypersensitivity pneumonitis.慢性过敏性肺炎的长期预后。
Allergy. 2019 May;74(5):944-952. doi: 10.1111/all.13692. Epub 2019 Jan 13.
10
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.特发性肺纤维化的诊断标准:弗利彻协会白皮书。
Lancet Respir Med. 2018 Feb;6(2):138-153. doi: 10.1016/S2213-2600(17)30433-2. Epub 2017 Nov 15.